| Combination of Coenzyme Q10 Intake and Moderate Physical Activity Counteracts Mitochondrial Dysfunctions in a SAMP8 Mouse Model C Andreani, C Bartolacci, M Guescini, M Battistelli, V Stocchi, F Orlando, ... Oxidative Medicine and Cellular Longevity 2018 (1), 8936251, 2018 | 120 | 2018 |
| The role of PIAS SUMO E3-ligases in cancer A Rabellino, C Andreani, PP Scaglioni Cancer research 77 (7), 1542-1547, 2017 | 115 | 2017 |
| Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer C Bartolacci, C Andreani, G Vale, S Berto, M Melegari, AC Crouch, ... Nature communications 13 (1), 4327, 2022 | 92 | 2022 |
| Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition C Kalogris, C Garulli, L Pietrella, V Gambini, S Pucciarelli, C Lucci, M Tilio, ... Biochemical pharmacology 90 (3), 226-234, 2014 | 77 | 2014 |
| Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6 JG Anderson, G Ramadori, RM Ioris, M Galiè, ED Berglund, KC Coate, ... Molecular metabolism 4 (11), 846-856, 2015 | 64 | 2015 |
| Lipid metabolism regulates oxidative stress and ferroptosis in RAS-driven cancers: a perspective on cancer progression and therapy C Bartolacci, C Andreani, Y El-Gammal, PP Scaglioni Frontiers in molecular biosciences 8, 706650, 2021 | 50 | 2021 |
| Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling C Garulli, C Kalogris, L Pietrella, C Bartolacci, C Andreani, M Falconi, ... Cellular signalling 26 (2), 352-362, 2014 | 49 | 2014 |
| Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor C Andreani, C Bartolacci, K Wijnant, R Crinelli, M Bianchi, M Magnani, ... Aging (Albany NY) 9 (2), 508, 2017 | 44 | 2017 |
| Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells S Palchetti, D Pozzi, C Marchini, A Amici, C Andreani, C Bartolacci, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (2), 681-691, 2017 | 38 | 2017 |
| Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer C Bartolacci, C Andreani, C Curcio, S Occhipinti, L Massaccesi, ... Cancer Immunology Research 6 (12), 1486-1498, 2018 | 33 | 2018 |
| In vitro and in vivo studies of gold (I) azolate/phosphane complexes for the treatment of basal like breast cancer V Gambini, M Tilio, EW Maina, C Andreani, C Bartolacci, J Wang, M Iezzi, ... European journal of medicinal chemistry 155, 418-427, 2018 | 30 | 2018 |
| Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib M Tilio, V Gambini, J Wang, C Garulli, C Kalogris, C Andreani, ... Cancer Letters 381 (1), 76-84, 2016 | 25 | 2016 |
| Walking a tightrope: a perspective of resveratrol effects on breast cancer C Bartolacci, C Andreani, A Amici, C Marchini Current Protein and Peptide Science 19 (3), 311-322, 2018 | 22 | 2018 |
| HER2-displaying M13 bacteriophages induce therapeutic immunity against breast cancer J Wang, A Lamolinara, L Conti, M Giangrossi, L Cui, MB Morelli, ... Cancers 14 (16), 4054, 2022 | 18 | 2022 |
| Ferroptosis: a specific vulnerability of RAS-driven cancers? C Andreani, C Bartolacci, PP Scaglioni Frontiers in Oncology 12, 923915, 2022 | 14 | 2022 |
| Roles of Ubiquitination and SUMOylation in the Regulation of Angiogenesis A Rabellino, C Andreani, PP Scaglioni Current Issues in Molecular Biology 35 (1), 109-126, 2020 | 11 | 2020 |
| SIRT6 promotes metastasis and relapse in HER2-positive breast cancer C Andreani, C Bartolacci, G Persico, F Casciaro, S Amatori, M Fanelli, ... Scientific reports 13 (1), 22000, 2023 | 7 | 2023 |
| Fatty acid synthase is a therapeutic target in mutant KRAS lung Cancer C Bartolacci, M Padanad, C Andreani, M Melegari, S Rindhe, K George, ... Journal of Thoracic Oncology 12 (8), S1538, 2017 | 7 | 2017 |
| Getting the most from gene delivery by repeated DNA transfections M Montani, C Marchini, GV Badillo Pazmay, C Andreani, C Bartolacci, ... Applied Physics Letters 106 (23), 2015 | 5 | 2015 |
| Coordinated targeting of S6K1/2 and AXL disrupts pyrimidine biosynthesis in PTEN-deficient glioblastoma CA Behrmann, KN Ennis, P Sarma, C Wetzel, NA Clark, KM Von Handorf, ... Cancer Research Communications 4 (8), 2215-2227, 2024 | 1 | 2024 |
Augusto AmiciRicercatore di Biologia ApplicataEmail verificata su unicam.it
